Six of the world’s ten most innovative humanoid robot startups are based in China, according to a report released by legal research platform LexisNexis on July 28, which evaluated private companies with demonstrated bipedal walking robots using a Patent Asset Index covering portfolio size, technological value, and geographic scope.
Chinese companies claimed the top five positions outright. Shanghai-based Fourier and AgiBot took the first two spots, followed by Shenzhen-based LimX Dynamics and Pudu Robotics, and Hangzhou-based Unitree Robotics. Shenzhen’s Leju Robot ranked ninth. Three U.S. companies made the top ten: Figure AI at sixth, Agility Robotics at tenth, and Apptronik at eighth. Germany’s Agile Robots ranked seventh as the sole European entrant.
What the Patent Data Shows
The LexisNexis ranking reflects not just the volume of patents filed in China but their assessed value – measured by market coverage and the degree to which subsequent innovations build upon them. That distinction matters: a large number of low-citation, single-jurisdiction patents would not produce the same ranking outcome as a smaller number of foundational, widely-cited, multi-jurisdiction filings.
The data shows acceleration across three key technical areas. Over the past decade, patent filings from China-based inventors doubled in interaction systems, expanded by 2.5 times in morphology – the form, shape, and structural design of robots – and grew fivefold in control and planning architectures. China’s share of aggregate global patent asset value in morphology reached 63% in 2025, up from 49% in 2020. The U.S. held 11% in 2025, slightly down from 12% five years earlier.
Commercial Deployment Aligned with IP Leadership
The patent ranking aligns with commercial deployment data. China accounted for more than four out of five global humanoid robot installations in 2025, according to Counterpoint Research. AgiBot held a 30.4% global market share and Unitree 26.4% – the same companies that appear near the top of the LexisNexis innovation ranking.
Morgan Stanley has revised its China humanoid shipment forecast upward twice in 2026, most recently to 50,000 units for the full year, with a $2 billion market expected to grow to $15 billion by 2030. The IP position LexisNexis documents is the foundation beneath that commercial trajectory.
The Policy Response
China’s accelerating position has prompted regulatory action in Washington. On July 28 – the same day LexisNexis published its report – the Trump administration announced import bans on new robots and power inverters citing national security concerns and supply chain vulnerabilities, without naming China explicitly. The U.S. House of Representatives has also voted to bar the Pentagon from procuring, leasing, or operating humanoid robotic systems linked to designated foreign adversaries including China, Russia, and Iran under Section 163 of this year’s National Defence Authorisation Act.
The policy developments reflect a recognition that the IP gap documented by LexisNexis has strategic implications beyond commercial competition. Control and planning architecture patents – the category where China’s share grew fivefold – determine how autonomous robots perceive, reason, and act. The military exclusion legislation signals that U.S. policymakers view humanoid robot AI capability, not just hardware manufacturing, as a national security-relevant technology.
Disclaimer: RobotsBeat is an independent media brand owned and operated by NuvexMedia LLC, publishing news, research, and insights on artificial intelligence, emerging technologies, automation, and related industries. NuvexMedia LLC invests in and collaborates with companies across the AI, Robotics, technology, software, and digital innovation sectors. These relationships do not influence RobotsBeat's editorial coverage, and the publication maintains full editorial independence to provide accurate, timely, and objective information. © 2026 NuvexMedia LLC. All rights reserved. This content is for informational purposes only and should not be considered legal, tax, investment, financial, or other professional advice.
